Bandingkan Harga & Kinerja Indo Komoditi Korpora Tbk. (INCF) vs Brigit Biofarmaka Teknologi Tbk. (OBAT)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Indo Komoditi Korpora Tbk. dan Brigit Biofarmaka Teknologi Tbk.: Indo Komoditi Korpora Tbk. diperdagangkan di Rp50 (kapitalisasi pasar 71,92 M), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp240 (kapitalisasi pasar 166,01 M, volume 24 jam 324 rb). Perbedaan utamanya: Brigit Biofarmaka Teknologi Tbk. jauh lebih besar — sekitar 2,3× kapitalisasi pasar Indo Komoditi Korpora Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| INCF | OBAT | |
|---|---|---|
Kapitalisasi Pasar | 71,92 M | 166,01 M |
Volume | — | 324 rb |
Lot | — | 3,24 rb |
Perputaran | — | 77,68 jt |
Harga Rata-rata | — | 239,75 |
Nilai Transaksi | — | 77,68 jt |
Harga Ekuilibrium Indikatif | — | 240 |
Volume Ekuilibrium Indikatif | — | 1 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Indo Komoditi Korpora Tbk.
PT Indo Komoditi Korpora Tbk (the Company) and its subsidiary (together referred as the "Group"), established in the Republic of Indonesia based on deed of establishment No. 125 dated February 23rd, 1982, made in the presence of Frederik Alexander Tumbuan, S.H., Notary in Jakarta, which the Company was originally named PT Indo Alaya Leasing Corporation.
Selengkapnya di halaman INCF →Tentang Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →
